Kbc Group Nv Ligand Pharmaceuticals Inc Transaction History

Kbc Group Nv

$33.1 Billion
Q2 2024

A detailed history of Kbc Group Nv transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Kbc Group Nv holds 604 shares of LGND stock, worth $68,481. This represents 0.0% of its overall portfolio holdings.

Number of Shares

604

Previous 604 -0.0%

Holding current value

$68,481

Previous $44,000 15.91%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$49.57 - $72.63 $30,981 - $45,393	-625 Reduced 50.85%	604 $43,000
Q3 2023 Feb 15, 2024	SELL	$58.86 - $72.67 $36,787 - $45,418	-625 Reduced 50.85%	604 $36,000
Q2 2023 Feb 15, 2024	SELL	$69.53 - $79.33 $14,045 - $16,024	-202 Reduced 14.12%	1,229 $89,000
Q1 2023 Feb 14, 2024	SELL	$65.67 - $77.08 $13,265 - $15,570	-202 Reduced 14.12%	1,229 $90,000
Q1 2023 May 04, 2023	SELL	$65.67 - $77.08 $13,265 - $15,570	-202 Reduced 14.12%	1,229 $90,000
Q3 2022 Feb 15, 2024	BUY	$0.01 - $107.56 $8 - $88,952	827 Added 136.92%	1,431 $123,000
Q2 2022 Feb 14, 2024	BUY	$74.52 - $117.06 $61,628 - $96,808	827 Added 136.92%	1,431 $128,000
Q2 2022 Jul 26, 2022	BUY	$74.52 - $117.06 $106,638 - $167,512	1,431 New	1,431 $128,000
Q1 2021 Apr 26, 2021	SELL	$99.52 - $215.83 $288,010 - $624,612	-2,894 Closed	0 $0
Q3 2020 Oct 28, 2020	BUY	$89.56 - $126.72 $130,757 - $185,011	1,460 Added 101.81%	2,894 $276,000
Q2 2020 Aug 10, 2020	SELL	$68.28 - $123.65 $1.39 Million - $2.52 Million	-20,350 Reduced 93.42%	1,434 $160,000
Q1 2020 May 04, 2020	SELL	$63.37 - $107.88 $1.17 Million - $1.98 Million	-18,396 Reduced 45.78%	21,784 $1.58 Million
Q4 2019 Feb 11, 2020	BUY	$96.94 - $113.59 $3.9 Million - $4.56 Million	40,180 New	40,180 $4.19 Million

Others Institutions Holding LGND

# of Institutions

249

Shares Held

17.7M

Call Options Held

61K

Put Options Held

7.8K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.91B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account